Mirvie

South San Francisco, United States

Mirvie is a biotech company that creates precise, actionable, and non-invasive tests for maternal-fetal health.

$23.7M raised

Aug 2025

Venture - Series Unknown

Top Investors

General CatalystBlackRockKhosla VenturesMayfield FundForesite Capital

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Mirvie raised?

Mirvie has raised $23.7M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in August 2025.

Who are Mirvie's investors?

Mirvie's investors include General Catalyst, BlackRock, Khosla Ventures, Mayfield Fund, Foresite Capital.

Where is Mirvie headquartered?

Mirvie is headquartered in South San Francisco, United States.

What does Mirvie do?

Mirvie is a biotech company that creates precise, actionable, and non-invasive tests for maternal-fetal health.

What stage is Mirvie at?

Mirvie is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 1, 2025.

MLA

"Mirvie — Funding & Investors." VCBacked, August 1, 2025, https://www.vcbacked.co/company/mirvie. Accessed June 4, 2026.

APA

VCBacked. (2025). Mirvie — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/mirvie

Wikipedia (cite web)

{{cite web |title=Mirvie — Funding & Investors |url=https://www.vcbacked.co/company/mirvie |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 1, 2025.